Guidelines for the choice of intravenous fluids for vascular filling in critically ill patients, 2021.

Acute brain failure Fluid therapy Guidelines Haemorrhagic shock Sepsis or septic shock

Journal

Anaesthesia, critical care & pain medicine
ISSN: 2352-5568
Titre abrégé: Anaesth Crit Care Pain Med
Pays: France
ID NLM: 101652401

Informations de publication

Date de publication:
06 2022
Historique:
pubmed: 9 5 2022
medline: 22 6 2022
entrez: 8 5 2022
Statut: ppublish

Résumé

To provide recommendations for the appropriate choice of fluid therapy for resuscitation of critically ill patients. A consensus committee of 24 experts from the French Society of Anaesthesia and Intensive Care Medicine (Société française d'anesthésie et de réanimation, SFAR) and the French Society of Emergency Medicine (Société française de médecine d'urgence, SFMU) was convened. A formal conflict-of-interest policy was developed at the onset of the process and enforced throughout. The entire guideline elaboration process was conducted independently of any industry funding. The authors were advised to follow the principles of the Grading of Recommendations Assessment, Development and Evaluation (GRADE) system to guide their assessment of quality of evidence. The potential drawbacks of making strong recommendations in the presence of low-quality evidence were emphasised. Some recommendations were left ungraded. Four fields were defined: patients with sepsis or septic shock, patients with haemorrhagic shock, patients with acute brain failure, and patients during the peripartum period. For each field, the panel focused on two questions: (1) Does the use of colloids, as compared to crystalloids, reduce morbidity and mortality, and (2) Does the use of some specific crystalloids effectively reduce morbidity and mortality. Population, intervention, comparison, and outcomes (PICO) questions were reviewed and updated as needed, and evidence profiles were generated. The analysis of the literature and the recommendations were then conducted according to the GRADE methodology. The SFAR/SFMU guideline panel provided nine statements on the appropriate choice of fluid therapy for resuscitation of critically ill patients. After two rounds of rating and various amendments, strong agreement was reached for 100% of the recommendations. Out of these recommendations, two have a high level of evidence (Grade 1 +/-), six have a moderate level of evidence (Grade 2 +/-), and one is based on expert opinion. Finally, no recommendation was formulated for two questions. Substantial agreement among experts has been obtained to provide a sizable number of recommendations aimed at optimising the choice of fluid therapy for resuscitation of critically ill patients.

Identifiants

pubmed: 35526312
pii: S2352-5568(22)00039-X
doi: 10.1016/j.accpm.2022.101058
pii:
doi:

Types de publication

Practice Guideline Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

101058

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2022 The Authors. Published by Elsevier Masson SAS.. All rights reserved.

Auteurs

Olivier Joannes-Boyau (O)

Service d'Anesthésie-Réanimation SUD, CHU de Bordeaux, Hôpital Magellan, Bordeaux, France. Electronic address: olivier.joannes-boyau@chu-bordeaux.fr.

Philippe Le Conte (P)

Nantes Université, Faculté de Médecine, CHU de Nantes, Service des Urgences, Nantes, France.

Marie-Pierre Bonnet (MP)

Sorbonne Université, Service d'Anesthésie-Réanimation, Hôpital Trousseau, DMU DREAM, GRC 29, APHP, Paris, France; INSERM U1153, Equipe de Recherche en Epidémiologie Obstétricale, Périnatale et Pédiatrique (EPOPé), Centre de Recherche Epidémiologie et Statistique Sorbonne Paris Cité, Paris, France.

Eric Cesareo (E)

Samu 69, Hôpital Édouard-Herriot, Hospices Civils de Lyon, 5, Place d'Arsonval, F-69437 Lyon Cedex 03, France.

Benjamin Chousterman (B)

APHP, CHU Lariboisière, Département d'Anesthésie-Réanimation, DMU PARABOL, FHU, PROMICE, Paris, France; Université de Paris, INSERM U942 MASCOT, Paris, France.

Djamila Chaiba (D)

Service des Urgences Médico-Chirurgicales, Hôpital Simone Veil, Eaubonne, France.

Bénédicte Douay (B)

SMUR/Service des Urgences, Hôpital Beaujon, AP-HP Nord, Clichy, France.

Emmanuel Futier (E)

Centre Hospitalier Universitaire (CHU) Clermont-Ferrand, Département Anesthésie et Réanimation, Hôpital Estaing, Clermont-Ferrand, France; Université Clermont Auvergne, CNRS, Inserm U-1103, Clermont-Ferrand, France.

Anatole Harrois (A)

Service d'Anesthésie-Réanimation et Médecine Périopératoire, Hôpital Bicêtre, Assistance Publique Hôpitaux de Paris (APHP), Université Paris-Saclay, Paris, France.

Catherine Huraux (C)

Clinique des Cèdres, Grenoble, France.

Carole Ichai (C)

Université Côte D'Azur, Centre Hospitalier Universitaire de Nice, Hôpital Pasteur 2, Service de Réanimation Polyvalente, Nice, France.

Eric Meaudre Desgouttes (E)

Service Anesthésiologie-Réanimation Chirurgicale, Hôpital d'Instruction des Armées Sainte Anne, Toulon, France.

Olivier Mimoz (O)

Service des Urgences Adultes & SAMU 86, CHU de Poitiers, Poitiers, France; Faculté de Médecine et de Pharmacie, Université de Poitiers, Poitiers, France; Inserm U1070, Pharmacology of Antimicrobial Agents, Poitiers, France.

Laurent Muller (L)

UR-UM103 IMAGINE, Univ Montpellier, Division of Anesthesia Critical Care, Pain and Emergency Medicine, CHU Nîmes, Montpellier, France.

Mathieu Oberlin (M)

Structure des Urgences, Hôpitaux Universitaires de Strasbourg, Strasbourg, France.

Nicolas Peschanski (N)

Service des Urgences-SAMU-SMUR-CHU Rennes, Rennes, France; Faculté de Médecine-Université Rennes-1, Rennes, France.

Hervé Quintard (H)

Service des Soins Intensifs Adultes, Hôpitaux Universitaires de Genève, Switzerland.

Geoffroy Rousseau (G)

Département de Médecine d'Urgences, CHRU Tours, Tours, France.

Dominique Savary (D)

Département de Médecine d'Urgence, CHU d'Angers, Angers, France.

Alexy Tran-Dinh (A)

Service d'Anesthésie-Réanimation, Hôpital Bichat-Claude Bernard, Assistance Publique-Hôpitaux de Paris (AP-HP), Université Paris Cité, Paris, France.

Barbara Villoing (B)

SAU-SMUR, CHU Cochin Hôtel Dieu, Assistance Publique Hôpitaux de Paris (APHP), Paris, France.

Anthony Chauvin (A)

Services des Urgences/SMUR, Hôpital Lariboisière, Université de Paris Cité, Paris, France.

Emmanuel Weiss (E)

Service Anesthésie-Réanimation, Hôpital Beaujon, DMU PARABOL, AP-HP Nord, Clichy, France; Centre de Recherche sur l'Inflammation, UMR_S1149, Université de Paris, Paris, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH